vs
Side-by-side financial comparison of IOVANCE BIOTHERAPEUTICS, INC. (IOVA) and Mastech Digital, Inc. (MHH). Click either name above to swap in a different company.
IOVANCE BIOTHERAPEUTICS, INC. is the larger business by last-quarter revenue ($86.8M vs $45.5M, roughly 1.9× Mastech Digital, Inc.). On growth, IOVANCE BIOTHERAPEUTICS, INC. posted the faster year-over-year revenue change (17.7% vs -10.4%). Mastech Digital, Inc. produced more free cash flow last quarter ($4.3M vs $-61.9M). Over the past eight quarters, IOVANCE BIOTHERAPEUTICS, INC.'s revenue compounded faster (1001.6% CAGR vs -1.5%).
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.
IOVA vs MHH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.8M | $45.5M |
| Net Profit | — | $972.0K |
| Gross Margin | 67.4% | 28.3% |
| Operating Margin | -84.7% | 2.2% |
| Net Margin | — | 2.1% |
| Revenue YoY | 17.7% | -10.4% |
| Net Profit YoY | — | 227.3% |
| EPS (diluted) | — | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.8M | $45.5M | ||
| Q3 25 | $67.5M | $48.5M | ||
| Q2 25 | $60.0M | $49.1M | ||
| Q1 25 | $49.3M | $48.3M | ||
| Q4 24 | $73.7M | $50.7M | ||
| Q3 24 | $58.6M | $51.8M | ||
| Q2 24 | $31.1M | $49.5M | ||
| Q1 24 | $715.0K | $46.8M |
| Q4 25 | — | $972.0K | ||
| Q3 25 | $-91.3M | $941.0K | ||
| Q2 25 | $-111.7M | $135.0K | ||
| Q1 25 | $-116.2M | $-1.4M | ||
| Q4 24 | — | $297.0K | ||
| Q3 24 | $-83.5M | $1.9M | ||
| Q2 24 | $-97.1M | $1.4M | ||
| Q1 24 | $-113.0M | $-161.0K |
| Q4 25 | 67.4% | 28.3% | ||
| Q3 25 | 43.0% | 27.8% | ||
| Q2 25 | 5.5% | 28.1% | ||
| Q1 25 | -0.8% | 26.7% | ||
| Q4 24 | 68.7% | 29.0% | ||
| Q3 24 | 46.2% | 28.5% | ||
| Q2 24 | -0.8% | 28.2% | ||
| Q1 24 | — | 25.9% |
| Q4 25 | -84.7% | 2.2% | ||
| Q3 25 | -140.7% | 1.7% | ||
| Q2 25 | -189.8% | 0.1% | ||
| Q1 25 | -245.8% | -3.8% | ||
| Q4 24 | -117.5% | 0.1% | ||
| Q3 24 | -152.1% | 4.7% | ||
| Q2 24 | -327.6% | 3.4% | ||
| Q1 24 | -16464.6% | -0.9% |
| Q4 25 | — | 2.1% | ||
| Q3 25 | -135.3% | 1.9% | ||
| Q2 25 | -186.2% | 0.3% | ||
| Q1 25 | -235.5% | -3.0% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | -142.7% | 3.6% | ||
| Q2 24 | -312.2% | 2.8% | ||
| Q1 24 | -15800.8% | -0.3% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | $-0.33 | $0.01 | ||
| Q1 25 | $-0.36 | $-0.12 | ||
| Q4 24 | $-0.24 | $0.01 | ||
| Q3 24 | $-0.28 | $0.16 | ||
| Q2 24 | $-0.34 | $0.12 | ||
| Q1 24 | $-0.42 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $297.0M | $36.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $698.6M | $89.3M |
| Total Assets | $913.2M | $111.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $297.0M | $36.5M | ||
| Q3 25 | $300.8M | $32.7M | ||
| Q2 25 | $301.2M | $27.9M | ||
| Q1 25 | $359.7M | $24.7M | ||
| Q4 24 | $323.8M | $27.7M | ||
| Q3 24 | $397.5M | $23.9M | ||
| Q2 24 | $412.5M | $20.6M | ||
| Q1 24 | $356.2M | $19.4M |
| Q4 25 | $698.6M | $89.3M | ||
| Q3 25 | $702.3M | $88.0M | ||
| Q2 25 | $698.5M | $87.8M | ||
| Q1 25 | $767.9M | $86.9M | ||
| Q4 24 | $710.4M | $87.4M | ||
| Q3 24 | $773.5M | $86.5M | ||
| Q2 24 | $768.5M | $84.0M | ||
| Q1 24 | $680.0M | $81.7M |
| Q4 25 | $913.2M | $111.8M | ||
| Q3 25 | $904.9M | $112.6M | ||
| Q2 25 | $907.4M | $110.4M | ||
| Q1 25 | $966.7M | $110.1M | ||
| Q4 24 | $910.4M | $111.5M | ||
| Q3 24 | $991.1M | $111.5M | ||
| Q2 24 | $964.3M | $107.5M | ||
| Q1 24 | $869.8M | $106.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-52.6M | $4.4M |
| Free Cash FlowOCF − Capex | $-61.9M | $4.3M |
| FCF MarginFCF / Revenue | -71.3% | 9.5% |
| Capex IntensityCapex / Revenue | 10.7% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 4.48× |
| TTM Free Cash FlowTrailing 4 quarters | $-336.2M | $10.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-52.6M | $4.4M | ||
| Q3 25 | $-78.7M | $6.5M | ||
| Q2 25 | $-67.4M | $3.3M | ||
| Q1 25 | $-103.7M | $-3.0M | ||
| Q4 24 | $-73.3M | $4.0M | ||
| Q3 24 | $-59.0M | $3.3M | ||
| Q2 24 | $-98.4M | $1.2M | ||
| Q1 24 | $-122.3M | $-1.3M |
| Q4 25 | $-61.9M | $4.3M | ||
| Q3 25 | $-89.5M | $6.3M | ||
| Q2 25 | $-74.9M | $3.2M | ||
| Q1 25 | $-109.9M | $-3.1M | ||
| Q4 24 | $-77.5M | $3.9M | ||
| Q3 24 | $-61.3M | $3.2M | ||
| Q2 24 | $-98.9M | $707.0K | ||
| Q1 24 | $-126.5M | $-1.6M |
| Q4 25 | -71.3% | 9.5% | ||
| Q3 25 | -132.7% | 13.0% | ||
| Q2 25 | -124.9% | 6.6% | ||
| Q1 25 | -222.8% | -6.4% | ||
| Q4 24 | -105.1% | 7.7% | ||
| Q3 24 | -104.6% | 6.2% | ||
| Q2 24 | -317.9% | 1.4% | ||
| Q1 24 | -17685.3% | -3.4% |
| Q4 25 | 10.7% | 0.1% | ||
| Q3 25 | 16.1% | 0.4% | ||
| Q2 25 | 12.4% | 0.1% | ||
| Q1 25 | 12.6% | 0.2% | ||
| Q4 24 | 5.7% | 0.2% | ||
| Q3 24 | 3.9% | 0.1% | ||
| Q2 24 | 1.4% | 1.0% | ||
| Q1 24 | 583.4% | 0.6% |
| Q4 25 | — | 4.48× | ||
| Q3 25 | — | 6.88× | ||
| Q2 25 | — | 24.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 13.60× | ||
| Q3 24 | — | 1.76× | ||
| Q2 24 | — | 0.85× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IOVA
| Amtagvi | $64.9M | 75% |
| Proleukin | $21.9M | 25% |
MHH
| IT Staffing Services | $37.6M | 83% |
| Data And Analytics Services | $7.8M | 17% |
